StockWatch
·
Pharmaceuticals
Corporate Governance5 Aug 2026, 02:37 pm

Haleos Labs Reappoints Two Independent Directors for 5 Years

AI Summary

Haleos Labs Ltd announced the reappointment of Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam as Independent Directors for a second consecutive term of 5 years, effective November 13, 2026. This decision, approved by the Board of Directors based on the Nomination and Remuneration Committee's recommendation, is subject to shareholder approval. Dr. Malakondaiah, a retired IPS officer, brings extensive administrative and leadership experience. Dr. Samavedam is a renowned Critical Care Medicine specialist with over 26 years of experience. Both directors have been serving the company since November 13, 2021.

Key Highlights

  • Two Independent Directors reappointed for a second 5-year term.
  • Reappointment effective from November 13, 2026.
  • Subject to shareholder approval.
  • Directors bring expertise in public administration and critical care medicine.